Beta-blockers are still crucial for some, but new research calls into question the benefit for a large proportion of patients ...

Therapeutic effects were sustained off treatment, with persistent reduction in HbA1c and improvement in beta-cell function 3 months after last dose, suggesting disease-modifying potential of ...

Introduction Millions of people worldwide rely on beta blockers to manage cardiovascular risks, especially following a heart attack. However, recent studies are challenging the long-held belief that ...

Imagine someone you care about suddenly experiencing chest pain, turning pale, and breathing heavily. These are some of the ...

Two new trials and a meta-analysis presented at the European Society of Cardiology Congress put the spotlight on the use of beta-blocker therapy after myocardial infarction in patients with preserved ...

Type 1 diabetes is an autoimmune disease characterized by progressive loss of pancreatic beta cells. Golimumab is a human monoclonal antibody specific for tumor necrosis factor α that has already been ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A single 14-day course of the monoclonal ...

Beta blockers may provide no clinical benefit to patients who maintain normal heart function following a heart attack, according to a study published Aug. 30 in The New England Journal of Medicine. ...